FPGS 1994 A > G polymorphism reported to have no effect on MTX efficacy or toxicity [45], although there was an association between FPGS mRNA expression in peripheral blood mononuclear cells and a poor response to MTX in RA patients with that genotype [46]. This evidence concerns the gene FPGS and rheumatoid arthritis.